Total Payments
$11,115
2024 Payments
$1,643
Companies
27
Transactions
690
Medicare Patients
1,447
Medicare Billing
$103,320
Payment Breakdown by Category
Food & Beverage$10,660 (95.9%)
Education$455.06 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,660 | 679 | 95.9% |
| Education | $455.06 | 11 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,699 | 116 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $1,421 | 83 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,385 | 82 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,104 | 61 | $0 (2024) |
| ABBVIE INC. | $934.41 | 84 | $0 (2024) |
| Alkermes, Inc. | $817.10 | 44 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $626.56 | 34 | $0 (2024) |
| Lundbeck LLC | $449.64 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $429.05 | 26 | $0 (2024) |
| ITI, Inc. | $400.99 | 21 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,643 | 98 | Teva Pharmaceuticals USA, Inc. ($526.92) |
| 2023 | $1,793 | 96 | Teva Pharmaceuticals USA, Inc. ($406.03) |
| 2022 | $1,718 | 111 | Alkermes, Inc. ($239.33) |
| 2021 | $1,361 | 91 | AbbVie Inc. ($274.20) |
| 2020 | $1,023 | 64 | Sunovion Pharmaceuticals Inc. ($379.98) |
| 2019 | $1,605 | 104 | Sunovion Pharmaceuticals Inc. ($374.30) |
| 2018 | $916.45 | 65 | Sunovion Pharmaceuticals Inc. ($285.02) |
| 2017 | $1,056 | 61 | Sunovion Pharmaceuticals Inc. ($357.23) |
All Payment Transactions
690 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Central Nervous System | ||||||
| 11/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Central Nervous System | ||||||
| 11/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: CNS | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Neuropsychiatry | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: Neurology | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Neuropsychiatry | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.82 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.58 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Neurology | ||||||
| 09/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Neuropsychiatry | ||||||
| 09/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: CNS | ||||||
| 09/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 237 | 546 | $55,109 | $24,029 |
| 2022 | 4 | 270 | 608 | $56,775 | $25,702 |
| 2021 | 6 | 371 | 743 | $69,360 | $31,098 |
| 2020 | 7 | 569 | 1,028 | $62,495 | $22,490 |
Total Patients
1,447
Total Services
2,925
Medicare Billing
$103,320
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 193 | $30,282 | $14,050 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 181 | $19,230 | $8,639 | 44.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 138 | $4,442 | $899.78 | 20.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 22 | 34 | $1,156 | $440.00 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 171 | $26,331 | $13,104 | 49.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 240 | $24,386 | $11,045 | 45.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 22 | 154 | $4,596 | $1,121 | 24.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 23 | 43 | $1,462 | $431.87 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 131 | 233 | $39,928 | $16,987 | 42.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 78 | 162 | $8,804 | $4,928 | 56.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 79 | 93 | $10,540 | $4,881 | 46.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 35 | 52 | $4,457 | $2,852 | 64.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 25 | 176 | $4,713 | $1,182 | 25.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 23 | 27 | $918.00 | $268.98 | 29.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 195 | 330 | $20,901 | $6,102 | 29.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 124 | 149 | $15,269 | $4,970 | 32.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 93 | 147 | $6,781 | $4,783 | 70.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 38 | 51 | $3,784 | $2,643 | 69.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 39 | $6,138 | $1,762 | 28.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 29 | 228 | $6,766 | $1,502 | 22.2% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 54 | 84 | $2,856 | $727.64 | 25.5% |
About Dr. David Korman, M.D
Dr. David Korman, M.D is a Psychiatry healthcare provider based in Canton, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1942204755.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Korman, M.D has received a total of $11,115 in payments from pharmaceutical and medical device companies, with $1,643 received in 2024. These payments were reported across 690 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($10,660).
As a Medicare-enrolled provider, Korman has provided services to 1,447 Medicare beneficiaries, totaling 2,925 services with total Medicare billing of $103,320. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Canton, TX
- Active Since 06/09/2005
- Last Updated 06/12/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1942204755
Products in Payments
- LATUDA (Drug) $1,699
- VRAYLAR (Drug) $1,268
- REXULTI (Drug) $1,128
- INGREZZA (Drug) $1,104
- ARISTADA (Drug) $614.67
- CAPLYTA (Drug) $520.00
- ABILIFY MAINTENA (Drug) $500.53
- HETLIOZ (Drug) $457.04
- AUSTEDO (Drug) $399.69
- Austedo XR (Drug) $321.22
- UZEDY (Drug) $319.15
- TRINTELLIX (Drug) $243.13
- INVEGA SUSTENNA (Drug) $208.42
- NUEDEXTA (Drug) $198.01
- Auvelity (Drug) $155.33
- PERSERIS (Drug) $153.53
- SPRAVATO (Drug) $143.11
- Fanapt (Drug) $139.46
- Aristada 441 mg (Drug) $139.08
- Trintellix (Drug) $118.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Canton
Mr. Pradeep Manudhane, Md, MD
Psychiatry — Payments: $1.6M
Psychiatry $1.6M
Dr. Shishuka Malhotra, M.d, M.D
Psychiatry — Payments: $303,075
Psychiatry $303,075
Dr. John Vraciu, D.o, D.O
Psychiatry — Payments: $11,130
Psychiatry $11,130
Dr. Nalini Morris, D.o, D.O
Psychiatry — Payments: $10,062
Psychiatry $10,062
Mr. Kanubhai Patel, Md, MD
Psychiatry — Payments: $8,669
Psychiatry $8,669
Dr. Krishnan Sivaram, Md, MD
Psychiatry — Payments: $5,588
Psychiatry $5,588